1 rich Libsyn https://www.libsyn.com 300 600 Metabolic dysfunction-associated steatotic liver disease (MASLD) plays a pivotal role in cardiometabolic health, driven by its bidrectional relationship with cardiovascular disease (CVD) and its impact on long-term morbidity and mortality. This interdisciplinary vodcast explores the shared pathophysiologic pathways connecting MASLD and CVD and underscores the importance of comprehensive risk evaluation. A panel of experts discusses practical, evidence-based strategies for managing MASLD, including lifestyle interventions and the evolving landscape of pharmacologic therapies. The program highlights emerging cardiometabolic agents, including GLP 1-based therapies, ande their potential to slow disease progression and reduce cardiovascular risk in affected patients.&amp;nbsp; HeartBEATS from Lifelong Learning™ https://professional.heart.org/professional/EducationMeetings/UCM_475320_Education-Meetings.jsp <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41005915/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/201153845